dermaPACE® System

SANUWAVE’s dermaPACE System provides a simpler and better option for wound healing, making it a valuable advancement in the field of wound therapy.

The dermaPACE System activates the body’s normal regenerative processes, expedites curing at the cellular level and ultimately produces a robust and durable wound healing.

What can it treat?

dermaPACE Therapy has been clinically proven to promote the healing process for:

  • Diabetic Foot Ulcers (DFU)
How long does it take?

In general, only a few treatments lasting a few minutes are needed to jump-start the healing process and produce new, healthy tissue. Aftercare is simply the standard of wound care. Possible side effects include reddening, bruising, tingling, numbness or increased pain.

Is it effective?

The dermaPACE System offers an improved, noninvasive standard of care that may shorten an otherwise lengthy healing process. It is the first shockwave system to be FDA-cleared for the treatment of diabetic foot ulcers (DFU).*

Clinically Validated

The dermaPACE System is an advanced wound care device that utilizes pulsed acoustic cellular expression (PACE®) technology, a proprietary form of focused, extracorporeal shockwaves.

Shockwave technology has been used for nearly 30 years in orthopedic treatments for pain, fractures, etc., and with lithotripsy for breaking kidney stones. The PACE shockwave technology has the level of energy deposited inside the tissue specifically tuned to promote tissue healing, without any detrimental effects to the delicate cellular structures from the wound bed, periwound, or deep behind the skin level.

See Clinical Data

By activating the body’s normal regenerative process using high energy shockwaves, the dermaPACE System expedites healing at the cellular level.


The dermaPACE System is indicated in the US for the treatment of chronic Diabetic Foot Ulcers when used in conjunction with standard of care (de novo DEN160037).

Back to top